Cargando…

Recent Improvements in Genomic and Transcriptomic Understanding of Anaplastic and Poorly Differentiated Thyroid Cancers

Anaplastic thyroid cancer (ATC) is a lethal human cancer with a 5-year survival rate of less than 10%. Recently, its genomic and transcriptomic characteristics have been extensively elucidated over 5 years owing to advance in high throughput sequencing. These efforts have extended molecular understa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Seong-Keun, Song, Young Shin, Park, Young Joo, Seo, Jeong-Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090308/ https://www.ncbi.nlm.nih.gov/pubmed/32207263 http://dx.doi.org/10.3803/EnM.2020.35.1.44

Ejemplares similares

Genomic and Transcriptomic Characteristics According to Size of Papillary Thyroid Microcarcinoma
por: Song, Young Shin, et al.
Publicado: (2020)

CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer
por: Kim, Min Joo, et al.
Publicado: (2019)

The neutrophil to lymphocyte ratio can discriminate anaplastic thyroid cancer against poorly or well differentiated cancer
por: Cho, Jin-Seong, et al.
Publicado: (2015)

Transcriptome Network Analysis Reveals Aging-Related Mitochondrial and Proteasomal Dysfunction and Immune Activation in Human Thyroid
por: Cho, Byuri Angela, et al.
Publicado: (2018)

Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs
por: Prete, Alessandro, et al.
Publicado: (2021)

Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis
por: Song, Young Shin, et al.
Publicado: (2017)

Individualised Multimodal Treatment Strategies for Anaplastic and Poorly Differentiated Thyroid Cancer
por: Wächter, Sabine, et al.
Publicado: (2018)

Genomic Characterization of Differentiated Thyroid Carcinoma
por: Song, Young Shin, et al.
Publicado: (2019)

Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer
por: Yoo, Seong-Keun, et al.
Publicado: (2019)

Macrophage Densities Correlated with CXC Chemokine Receptor 4 Expression and Related with Poor Survival in Anaplastic Thyroid Cancer
por: Kim, Dae In, et al.
Publicado: (2016)

Recent Progress of Genome Study for Anaplastic Thyroid Cancer
por: Lee, Jieun, et al.
Publicado: (2013)

Contrast-enhanced CT-based Radiomics for the Differentiation of Anaplastic or Poorly Differentiated Thyroid Carcinoma from Differentiated Thyroid Carcinoma: A Pilot Study
por: Moon, Jayoung, et al.
Publicado: (2023)

Recent advances in the management of anaplastic thyroid cancer
por: De Leo, Simone, et al.
Publicado: (2020)

Development of Novel Follicular Thyroid Cancer Models Which Progress to Poorly Differentiated and Anaplastic Thyroid Cancer
por: Caperton, Caitlin O., et al.
Publicado: (2021)

Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
por: Dierks, Christine, et al.
Publicado: (2021)

The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy
por: Kasaian, Katayoon, et al.
Publicado: (2015)

Recent advances and emerging therapies in anaplastic thyroid carcinoma
por: Cabanillas, Maria E., et al.
Publicado: (2018)

Acute pyelonephritis with anaplastic thyroid carcinoma producing granulocyte colony-stimulating factor
por: Kang, Keunhee, et al.
Publicado: (2013)

Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?
por: Volante, Marco, et al.
Publicado: (2021)

Modeling the tumor microenvironment of anaplastic thyroid cancer: an orthotopic tumor model in C57BL/6 mice
por: Xu, Zhen, et al.
Publicado: (2023)

Characterization of the genomic alterations in poorly differentiated thyroid cancer
por: Lee, Yeeun, et al.
Publicado: (2023)

The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
por: Mika, Justyna, et al.
Publicado: (2020)

Poorly differentiated and anaplastic thyroid carcinomas: chromosomal and oligo-array profile of five new cell lines
por: Rodrigues, R F, et al.
Publicado: (2007)

Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience
por: Romei, Cristina, et al.
Publicado: (2018)

FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
por: Adam, Pia, et al.
Publicado: (2021)

Poorly differentiated thyroid carcinoma: An institutional experience
por: Choi, Seok Won, et al.
Publicado: (2020)

Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
por: Teng, Lianghong, et al.
Publicado: (2017)

Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics
por: Lu, Lina, et al.
Publicado: (2023)

Mutation Profile of Well-Differentiated Thyroid Cancer in Asians
por: Song, Young Shin, et al.
Publicado: (2015)

Treatment outcomes of radiotherapy for anaplastic thyroid cancer
por: Park, Jong Won, et al.
Publicado: (2018)

Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer—A New Diagnostic and Therapeutic Target?
por: Wächter, Sabine, et al.
Publicado: (2021)

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

Anoctamin-1 affects the migration and invasion of anaplastic thyroid carcinoma cells
por: Kim, Jae-Young, et al.
Publicado: (2019)

The value of immunocytochemical methods in the differential diagnosis of anaplastic thyroid tumours.
por: Ralfkiaer, N., et al.
Publicado: (1985)

Anaplastic thyroid carcinoma with chondrosarcomatous differentiation: a case report
por: Liu, Jixuan, et al.
Publicado: (2020)

BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
por: Wu, Yu, et al.
Publicado: (2019)

Detection of Survivin and COX-2 in Thyroid Carcinoma: Anaplastic Carcinoma Shows Overexpression of Nuclear Survivin and Low COX-2 Expression
por: Kim, Young A, et al.
Publicado: (2012)

Genomically Driven Precision Medicine to Improve Outcomes in Anaplastic Thyroid Cancer
por: Pinto, Nicole, et al.
Publicado: (2014)

Anaplastic Thyroid Carcinoma Initially Presented with Abdominal Cutaneous Mass and Hyperthyroidism
por: Lim, Kyu-Hyoung, et al.
Publicado: (2010)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qp1hi0vv7jjtb2dcrmfuucqb38